| Literature DB >> 34631005 |
Axel Wihlborg1, Karin Bergström2, Ingrid Bergström3, Paul Gerdhem1.
Abstract
PURPOSE: To assess site-specific volumetric bone and muscle changes, as well as demographic and biochemical changes, in postmenopausal women with a low-energy distal forearm fracture.Entities:
Year: 2021 PMID: 34631005 PMCID: PMC8497164 DOI: 10.1155/2021/1578543
Source DB: PubMed Journal: J Osteoporos ISSN: 2042-0064
Figure 1Recruitment of women with a forearm fracture and age-matched controls in the Distal Forearm Fracture (DFF) study.
Descriptive statistics of women with a distal forearm fracture and age-matched controls.
| Control | Fracture | Significance | |
|---|---|---|---|
|
|
| ||
| Mean (SD) | Mean (SD) |
| |
| Age (years) | 63.9 (7.7) | 65.5 (8.9) | 0.18 |
| Body height (m) | 1.64 (0.06) | 1.64 (0.06) | 0.84 |
| Body weight (kg) | 70.3 (12.8) | 68.8 (11.0) | 0.37 |
| BMI (kg/m2) | 26 (5) | 26 (4) | 0.50 |
| Serum calcium (mmol/L) | 2.38 (0.12) | 2.37 (0.09) | 0.30 |
| Parathyroid hormone (pmol/L) | 4.9 (2.3) | 4.7 (2.2) | 0.51 |
| PHPTa | 4 (4) | 4 (4) | 1.0 |
| 25OHD (nmol/L) | 59 (21) | 64 (24) | 0.13 |
| Vitamin D insufficiencyb | 31 (33) | 28 (27) | 0.38 |
| DXA | |||
| aBMD femoral neck (g/cm2) | 0.871 (0.122) | 0.810 (0.104) | <0.001 |
| | −1.2 (0.9) | −1.6 (0.7) | <0.001 |
| aBMD L1–L4 (g/cm2) | 1.114 (0.175) | 0.995 (0.130) | <0.001 |
| | −0.6 (1.4) | −1.5 (1.0) | <0.001 |
| Osteoporosisc | 17 (18) | 39 (38) | 0.001 |
Continuous variables are described as means and standard deviations (SD). Dichotomous variables are described as frequencies and percentages. BMI, body mass index; aBMD, areal bone mineral density by DXA.T-test. PHPT, vitamin D insufficiency and osteoporosis: Pearson's chi-squared test or Fischer's exact test Number (%). aPrimary hyperparathyroidism defined as PTH >9.6 pmol/L combined with calcium >2.5 mmol/L. b25OHD <50 nmol/L. cT-score ≤−2.5 in the hip or spine.
Descriptive statistics of women with a distal forearm fracture and age-matched controls, based on self-reported questionnaire.
| Control | Fracture | Significance | |
|---|---|---|---|
|
|
| ||
| Number (%) | Number (%) |
| |
| Completed questionnaire | 97 (98) | 99 (95) | 0.28 |
| Smoking | 8 (8) | 11 (11) | 0.50 |
| Alcohol use (units/day) | 0.54 (0.75) | 0.51 (0.71) | 0.76 |
| Walking one hour or more/day | 29 (31) | 46 (48) | 0.019 |
| History of a falla | 31 (32) | 69 (70) | <0.001 |
| History of multiple fallsb | 15 (15) | 34 (34) | 0.002 |
| History of osteoporosis-related fracture | 0 | 11 (6) | 0.001 |
|
| |||
|
| |||
| Kidney disease | 0 | 2 (2) | 0.50 |
| Rheumatic disease | 5 (5) | 8 (8) | 0.41 |
| Diabetes mellitus | 6 (6) | 4 (4) | 0.54 |
| Cancer | 11 (11) | 10 (10) | 0.78 |
|
| |||
|
| |||
| Estrogen use | 0 | 3 (3) | 0.25 |
| Cortisone use | 0 | 2 (2) | 0.50 |
| Vitamin D supplementation | 1 (1) | 7 (7) | 0.06 |
| Bisphosphonate use | 0 | 2 (2) | 0.50 |
Dichotomous variables are described as frequencies and percentages of those with completed questionnaires. Alcohol use is described as a continuous variable with mean and standard deviation (SD).Pearson's chi-squared test or Fischer's exact test. Alcohol use: T-test. Mean (SD). aReported at least one fall within 1 year prior to investigation point. bReported two or more falls within 1 year prior to investigation point.
Site-specific bone and muscle variables in the DFF cohort.
| Control | Fracture | Mean difference (CI) | Difference % | Significance | Significance | |
|---|---|---|---|---|---|---|
|
|
|
| ANCOVA | |||
| Mean (SD) | Mean (SD) |
|
| |||
| BMC total 4% (mg/mm) | 97.3 (19.5) | 84.8 (12.9) | −12.5 (−17.0 to −7.9) | 13 | <0.001 | <0.001 |
| BMD total 4% (mg/cm3) | 309.2 (63.3) | 256.8 (47.0) | −52.6 (−67.9 to 37.2) | 17 | <0.001 | <0.001 |
| BMD trabecular 4% (mg/cm3) | 167.5 (43.3) | 125.1 (31.7) | −42.4 (−52.9 to −31.9) | 25 | <0.001 | <0.001 |
| BMC total 66% (mg/mm) | 89.8 (16.5) | 81.4 (14.7) | −8.5 (−12.8 to −4.1) | 9 | <0.001 | 0.027 |
| BMD cortical 66% (mg/cm3) | 1120.8 (43.8) | 1095.7 (55.7) | −25.1 (−39.0 to −11.2) | 2 | <0.001 | 0.007 |
| aBMD UDR (g/cm2) | 0.392 (0.079) | 0.327 (0.060) | − 0.065 (−0.085 to −0.046) | 17 | <0.001 | <0.001 |
| aBMD 33% of radius (g/cm2) | 0.782 (0.104) | 0.731 (0.114) | −0.051 (−0.082 to −0.021) | 7 | 0.001 | 0.18 |
|
| ||||||
| CSA 4% (mm2) | 319.8 (56.3) | 336.4 (53.5) | 16.6 (1.4 to 31.8) | 5 | 0.033 | 0.037 |
| CSA 66% (mm2) | 130.3 (23.2) | 134.3 (26.8) | 4.0 (−3.0 to 10.9) | 3 | 0.26 | 0.38 |
| Cortical thickness (mm) | 1.996 (0.401) | 1.726 (0.409) | − 0.270 (− 0.382 to −0.158) | 14 | <0.001 | <0.001 |
| Periosteal circumference (mm) | 40.3 (3.5) | 40.9 (3.8) | 0.6 (−0.4 to 1.6) | 2 | 0.25 | 0.36 |
| Endosteal circumference (mm) | 27.8 (4.5) | 30.1 (5.3) | 2.3 (0.9 to 3.6) | 8 | 0.001 | 0.009 |
|
| ||||||
| SSIp (mm3) | 264.1 (57.8) | 253.0 (51.5) | −11.1 (−26.2 to 4.0) | 4.2 | 0.15 | 0.30 |
| SSIx (mm3) | 141.9 (33.4) | 134.6 (29.3) | −7.4 (−16.0 to 1.3) | 5.2 | 0.12 | 0.25 |
| SSIy (mm3) | 150.6 (36.1) | 142.1 (31.2) | −8.5 (−17.8 to 0.8) | 5.6 | 0.10 | 0.22 |
|
| ||||||
| Muscle area (mm2) | 2630.4 (355.6) | 2646.8 (370.8) | 16.4 (−84.5 to 117.2) | 1 | 0.75 | 0.24 |
| Muscle density (mg/cm3) | 74.1 (1.9) | 73.7 (2.1) | 0.5 (−1.0 to 0.1) | 1 | 0.12 | 0.17 |
Values are depicted as mean with standard deviation (SD) and mean difference with confidence interval (CI). BMC and BMD: bone mineral content and density assessed by pQCT; aBMD: areal bone mineral density by DXA; UDR: ultradistal radius; CSA: cross-sectional area; ANCOVA: analysis of covariance (covariates: age, BMI, 25OHD, and femoral neck aBMD) Bisphosphonate use and femoral neck aBMD not included as covariates.